Cervical cancer screening program in Thimphu, Bhutan: Population coverage and characteristics associated with screening attendance

BMC Women's Health

Volumn 14, Issue 1, 2014, Pages

  Baussano, Iacopo ^a   Tshomo, Ugyen ^b   Clifford, Gary M ^a   Tenet, Vanessa ^a   Tshokey, Tshokey ^b   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Royal Government of Bhutan   (Bhutan)

Author keywords

Bhutan; Cervical cancer; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BHUTAN; CANCER SCREENING; CONTRACEPTIVE BEHAVIOR; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTIPARA; OCCUPATION; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT ATTENDANCE; PATIENT PARTICIPATION; SEPARATED PERSON; SINGLE (MARITAL STATUS); UTERINE CERVIX CANCER; WIDOW;

EID: 84928651840     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/s12905-014-0147-0     Document Type: Article

References (24)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worlwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
2. Tshomo U, Franceschi S, Dorji D, Baussano I, Tenet V, Snijders PJ, Meijer CJ, Bleeker MC, Gheit T, Tommasino M, Clifford GM: Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis 2014, 14:408.
3. Sukvirach S, Smith JS, Tunsakul S, Munoz N, Kesararat V, Opasatian O, Chichareon S, Kaenploy V, Ashley R, Meijer CJ, Snijders PJ, Coursaget P, Franceschi S, Herrero R: Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003, 187:1246-1256.
4. Anh PT, Hieu NT, Herrero R, Vaccarella S, Smith JS, Thuy NT, Nga NH, Duc NB, Ashley R, Snijders PJ, Meijer CJ, Munoz N, Parkin DM, Franceschi S: Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003, 104:213-220.
5. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, Franceschi S: Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 2006, 95:1593-1597.
6. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJF, Huang RD, Sun LX, Meijer CJLM, Qiao YL, Franceschi S: Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006, 95:96-101.
7. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S: Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007, 121:1306-1311.
8. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ,Meijer CJ, Franceschi S, Pawlita M: Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008, 17:1731-1738.
9. Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygård M, Karki BS, Snijders PJ, Meijer CJ, Franceschi S: Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control 2010, 21:323-330.
10. Dhendup T, Tshering P: Cervical cancer knowledge and screening behaviors among female university graduates of year 2012 attending national graduate orientation program, Bhutan. BMC Womens Health 2014, 14:44.
11. Dorji T, Tshomo U: Early Implementation and Monitoring of HPV Vaccination in Bhutan. In World Cancer Report 2014. Edited by Stewart BW, Wild CP. Lyon: International Agency for Research on Cancer; 2014:317.
12. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ: GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002, 40:779-787.
13. Sasieni P, Adams J, Cuzick J: Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003, 89:88-93.
14. Matos E, Loria D, Amestoy G, Herrera L, Prince MA, Moreno J, Krunfly C, van den Brule AJ, Meijer CJ, Munoz N, Herrero R, Proyecto Concordia Collaborative Group: Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003, 30:593-599.
15. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJ, Meijer CJ, Franceschi S: Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004, 90:638-645.
16. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S: HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer 2009, 101:202-208.
17. Hammouda D, Clifford GM, Pallardy S, Ayyach G, Chekiri A, Boudrich A, Snijders PJ, van Kemenade FJ, Meijer CJ, Bouhadef A, Zitouni Z, Habib D, Ikezaren N, Franceschi S: Human papillomavirus infection in a population-based sample of women in Algiers, Algeria. Int J Cancer 2011, 128:2224-2229.
18. Raza SA, Franceschi S, Pallardy S, Malik FR, Avan BI, Zafar A, Ali SH, Pervez S, Serajuddaula S, Snijders PJ, van Kemenade FJ, Meijer CJ, Shershah S, Clifford GM: Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer 2010, 102:1657-1660.
19. Alibegashvili T, Clifford GM, Vaccarella S, Baidoshvili A, Gogiashvili L, Tsagareli Z, Kureli I, Snijders PJ, Heideman DA, van Kemenade FJ, Meijer CJ, Kordzaia D, Franceschi S: Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiol 2011, 35:465-470.
20. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, Bathija H, Heideman DA, van Kemenade FJ, Meijer CJ, Hosseini SJ, Franceschi S: Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer 2012, 131:E156-E161.
21. Sankaranarayanan R, Budukh AM, Rajkumar R: Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ 2001, 79:954-962.
22. IARC: IARC Handbooks of Cancer Prevention Volume 10: Cervix Cancer Screening. Lyon, France: IARC Press; 2005.
23. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S: Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907.
24. Verhoef VM, Bosgraaf RP, van Kemenade FJ, Rozendaal L, Heideman DA, Hesselink AT, Bekkers RL, Steenbergen RD, Massuger LF, Melchers WJ, Bulten J, Overbeek LI, Berkhof J, Snijders PJ, Meijer CJ: Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncol 2014, 15:315-322.